Report for Harris W

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development - Voros_2022_Front.Cardiovasc.Med_9_960419
Author(s) : Voros S , Bansal AT , Barnes MR , Narula J , Maurovich-Horvat P , Vazquez G , Marvasty IB , Brown BO , Voros ID , Harris W , Voros V , Dayspring T , Neff D , Greenfield A , Furchtgott L , Church B , Runge K , Khalil I , Hayete B , Lucero D , Remaley AT , Newton RS
Ref : Front Cardiovasc Med , 9 :960419 , 2022
Abstract : Voros_2022_Front.Cardiovasc.Med_9_960419
ESTHER : Voros_2022_Front.Cardiovasc.Med_9_960419
PubMedSearch : Voros_2022_Front.Cardiovasc.Med_9_960419
PubMedID: 36684605

Title : Effects of sub-lethal neurite outgrowth inhibitory concentrations of chlorpyrifos oxon on cytoskeletal proteins and acetylcholinesterase in differentiating N2a cells - Flaskos_2011_Toxicol.Appl.Pharmacol_256_330
Author(s) : Flaskos J , Nikolaidis E , Harris W , Sachana M , Hargreaves AJ
Ref : Toxicol Appl Pharmacol , 256 :330 , 2011
Abstract : Flaskos_2011_Toxicol.Appl.Pharmacol_256_330
ESTHER : Flaskos_2011_Toxicol.Appl.Pharmacol_256_330
PubMedSearch : Flaskos_2011_Toxicol.Appl.Pharmacol_256_330
PubMedID: 21704052

Title : Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines - Harris_2009_Toxicol.In.Vitro_23_1559
Author(s) : Harris W , Munoz D , Bonner PL , Hargreaves AJ
Ref : Toxicol In Vitro , 23 :1559 , 2009
Abstract : Harris_2009_Toxicol.In.Vitro_23_1559
ESTHER : Harris_2009_Toxicol.In.Vitro_23_1559
PubMedSearch : Harris_2009_Toxicol.In.Vitro_23_1559
PubMedID: 19735718

Title : Proteomic analysis of differentiating neuroblastoma cells treated with sub-lethal neurite inhibitory concentrations of diazinon: identification of novel biomarkers of effect - Harris_2009_Toxicol.Appl.Pharmacol_240_159
Author(s) : Harris W , Sachana M , Flaskos J , Hargreaves AJ
Ref : Toxicol Appl Pharmacol , 240 :159 , 2009
Abstract : Harris_2009_Toxicol.Appl.Pharmacol_240_159
ESTHER : Harris_2009_Toxicol.Appl.Pharmacol_240_159
PubMedSearch : Harris_2009_Toxicol.Appl.Pharmacol_240_159
PubMedID: 19647006

Title : Diazinon oxon affects the differentiation of mouse N2a neuroblastoma cells - Sidiropoulou_2009_Arch.Toxicol_83_373
Author(s) : Sidiropoulou E , Sachana M , Flaskos J , Harris W , Hargreaves AJ , Woldehiwet Z
Ref : Archives of Toxicology , 83 :373 , 2009
Abstract : Sidiropoulou_2009_Arch.Toxicol_83_373
ESTHER : Sidiropoulou_2009_Arch.Toxicol_83_373
PubMedSearch : Sidiropoulou_2009_Arch.Toxicol_83_373
PubMedID: 18633600

Title : The effects of diazinon and cypermethrin on the differentiation of neuronal and glial cell lines - Flaskos_2007_Toxicol.Appl.Pharmacol_219_172
Author(s) : Flaskos J , Harris W , Sachana M , Munoz D , Tack J , Hargreaves AJ
Ref : Toxicol Appl Pharmacol , 219 :172 , 2007
Abstract : Flaskos_2007_Toxicol.Appl.Pharmacol_219_172
ESTHER : Flaskos_2007_Toxicol.Appl.Pharmacol_219_172
PubMedSearch : Flaskos_2007_Toxicol.Appl.Pharmacol_219_172
PubMedID: 17239417

Title : Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1\/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity - Hargreaves_2006_Biochem.Pharmacol_71_1240
Author(s) : Hargreaves AJ , Fowler MJ , Sachana M , Flaskos J , Bountouri M , Coutts IC , Glynn P , Harris W , Graham McLean W
Ref : Biochemical Pharmacology , 71 :1240 , 2006
Abstract : Hargreaves_2006_Biochem.Pharmacol_71_1240
ESTHER : Hargreaves_2006_Biochem.Pharmacol_71_1240
PubMedSearch : Hargreaves_2006_Biochem.Pharmacol_71_1240
PubMedID: 16499876